Cover Image

Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health threat. In a prospective multicentric study, we identify IL-3 as an independent prognostic marker for the outcome during SARS-CoV-2 infections. Specifically, low plasma IL-3 levels is associated with increased severit...

Full description

Saved in:
Bibliographic Details
Main Authors: Bénard, Alan (Author) , Jacobsen, Anne (Author) , Brunner, Maximilian (Author) , Krautz, Christian (Author) , Klösch, Bettina (Author) , Swierzy, Izabela (Author) , Naschberger, Elisabeth (Author) , Podolska, Malgorzata J. (Author) , Kouhestani, Dina (Author) , David, Paul (Author) , Birkholz, Torsten (Author) , Castellanos, Ixchel (Author) , Trufa, Denis (Author) , Sirbu, Horia (Author) , Vetter, Marcel (Author) , Kremer, Andreas E. (Author) , Hildner, Kai (Author) , Hecker, Andreas (Author) , Edinger, Fabian (Author) , Tenbusch, Matthias (Author) , Mühl-Zürbes, Petra (Author) , Steinkasserer, Alexander (Author) , Richter, Enrico (Author) , Streeck, Hendrik (Author) , Berger, Marc Moritz (Author) , Brenner, Thorsten (Author) , Weigand, Markus A. (Author) , Swirski, Filip K. (Author) , Schett, Georg (Author) , Grützmann, Robert (Author) , Weber, Georg Ferdinand (Author)
Format: Article (Journal)
Language:English
Published: 18 February 2021
In: Nature Communications
Year: 2021, Volume: 12, Pages: 1-8
ISSN:2041-1723
DOI:10.1038/s41467-021-21310-4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41467-021-21310-4
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41467-021-21310-4
Get full text
Author Notes:Alan Bénard, Anne Jacobsen, Maximilian Brunner, Christian Krautz, Bettina Klösch, Izabela Swierzy, Elisabeth Naschberger, Malgorzata J. Podolska, Dina Kouhestani, Paul David, Torsten Birkholz, Ixchel Castellanos, Denis Trufa, Horia Sirbu, Marcel Vetter, Andreas E. Kremer, Kai Hildner, Andreas Hecker, Fabian Edinger, Matthias Tenbusch, Petra Mühl-Zürbes, Alexander Steinkasserer, Enrico Richter, Hendrik Streeck, Marc M. Berger, Thorsten Brenner, Markus A. Weigand, Filip K. Swirski, Georg Schett, Robert Grützmann & Georg F. Weber

MARC

LEADER 00000caa a2200000 c 4500
001 175353416X
003 DE-627
005 20251105152022.0
007 cr uuu---uuuuu
008 210409s2021 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41467-021-21310-4  |2 doi 
035 |a (DE-627)175353416X 
035 |a (DE-599)KXP175353416X 
035 |a (OCoLC)1341403860 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bénard, Alan  |e VerfasserIn  |0 (DE-588)1240425333  |0 (DE-627)1768410941  |4 aut 
245 1 0 |a Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections  |c Alan Bénard, Anne Jacobsen, Maximilian Brunner, Christian Krautz, Bettina Klösch, Izabela Swierzy, Elisabeth Naschberger, Malgorzata J. Podolska, Dina Kouhestani, Paul David, Torsten Birkholz, Ixchel Castellanos, Denis Trufa, Horia Sirbu, Marcel Vetter, Andreas E. Kremer, Kai Hildner, Andreas Hecker, Fabian Edinger, Matthias Tenbusch, Petra Mühl-Zürbes, Alexander Steinkasserer, Enrico Richter, Hendrik Streeck, Marc M. Berger, Thorsten Brenner, Markus A. Weigand, Filip K. Swirski, Georg Schett, Robert Grützmann & Georg F. Weber 
246 3 0 |a three two 
264 1 |c 18 February 2021 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 02.09.2021 
520 |a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health threat. In a prospective multicentric study, we identify IL-3 as an independent prognostic marker for the outcome during SARS-CoV-2 infections. Specifically, low plasma IL-3 levels is associated with increased severity, viral load, and mortality during SARS-CoV-2 infections. Patients with severe COVID-19 exhibit also reduced circulating plasmacytoid dendritic cells (pDCs) and low plasma IFNα and IFNλ levels when compared to non-severe COVID-19 patients. In a mouse model of pulmonary HSV-1 infection, treatment with recombinant IL-3 reduces viral load and mortality. Mechanistically, IL-3 increases innate antiviral immunity by promoting the recruitment of circulating pDCs into the airways by stimulating CXCL12 secretion from pulmonary CD123+ epithelial cells, both, in mice and in COVID-19 negative patients exhibiting pulmonary diseases. This study identifies IL-3 as a predictive disease marker for SARS-CoV-2 infections and as a potential therapeutic target for pulmunory viral infections. 
700 1 |a Jacobsen, Anne  |e VerfasserIn  |4 aut 
700 1 |a Brunner, Maximilian  |e VerfasserIn  |4 aut 
700 1 |a Krautz, Christian  |e VerfasserIn  |4 aut 
700 1 |a Klösch, Bettina  |e VerfasserIn  |4 aut 
700 1 |a Swierzy, Izabela  |e VerfasserIn  |4 aut 
700 1 |a Naschberger, Elisabeth  |e VerfasserIn  |4 aut 
700 1 |a Podolska, Malgorzata J.  |e VerfasserIn  |4 aut 
700 1 |a Kouhestani, Dina  |e VerfasserIn  |4 aut 
700 1 |a David, Paul  |e VerfasserIn  |4 aut 
700 1 |a Birkholz, Torsten  |e VerfasserIn  |4 aut 
700 1 |a Castellanos, Ixchel  |e VerfasserIn  |4 aut 
700 1 |a Trufa, Denis  |e VerfasserIn  |4 aut 
700 1 |a Sirbu, Horia  |e VerfasserIn  |4 aut 
700 1 |a Vetter, Marcel  |e VerfasserIn  |4 aut 
700 1 |a Kremer, Andreas E.  |e VerfasserIn  |4 aut 
700 1 |a Hildner, Kai  |e VerfasserIn  |4 aut 
700 1 |a Hecker, Andreas  |d 1981-  |e VerfasserIn  |0 (DE-588)138849196  |0 (DE-627)606164340  |0 (DE-576)30933733X  |4 aut 
700 1 |a Edinger, Fabian  |e VerfasserIn  |4 aut 
700 1 |a Tenbusch, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Mühl-Zürbes, Petra  |e VerfasserIn  |4 aut 
700 1 |a Steinkasserer, Alexander  |e VerfasserIn  |4 aut 
700 1 |a Richter, Enrico  |e VerfasserIn  |4 aut 
700 1 |a Streeck, Hendrik  |e VerfasserIn  |4 aut 
700 1 |8 1\p  |a Berger, Marc Moritz  |d 1973-  |e VerfasserIn  |0 (DE-588)124376010  |0 (DE-627)70661786X  |0 (DE-576)294144196  |4 aut 
700 1 |a Brenner, Thorsten  |d 1978-  |e VerfasserIn  |0 (DE-588)130125709  |0 (DE-627)491713363  |0 (DE-576)189360607  |4 aut 
700 1 |a Weigand, Markus A.  |d 1967-  |e VerfasserIn  |0 (DE-588)1064970435  |0 (DE-627)815375239  |0 (DE-576)424658666  |4 aut 
700 1 |a Swirski, Filip K.  |e VerfasserIn  |4 aut 
700 1 |a Schett, Georg  |e VerfasserIn  |4 aut 
700 1 |a Grützmann, Robert  |e VerfasserIn  |4 aut 
700 1 |a Weber, Georg Ferdinand  |d 1979-  |e VerfasserIn  |0 (DE-588)133061191  |0 (DE-627)533313600  |0 (DE-576)299596834  |4 aut 
773 0 8 |i Enthalten in  |t Nature Communications  |d [London] : Springer Nature, 2010  |g 12(2021), Artikel-ID 1112, Seite 1-8  |h Online-Ressource  |w (DE-627)626457688  |w (DE-600)2553671-0  |w (DE-576)331555905  |x 2041-1723  |7 nnas  |a Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections 
773 1 8 |g volume:12  |g year:2021  |g elocationid:1112  |g pages:1-8  |g extent:8  |a Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections 
856 4 0 |u https://doi.org/10.1038/s41467-021-21310-4  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41467-021-21310-4  |x Verlag  |z lizenzpflichtig  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20210409 
993 |a Article 
994 |a 2021 
998 |g 1064970435  |a Weigand, Markus A.  |m 1064970435:Weigand, Markus A.  |d 910000  |d 910300  |e 910000PW1064970435  |e 910300PW1064970435  |k 0/910000/  |k 1/910000/910300/  |p 27 
998 |g 130125709  |a Brenner, Thorsten  |m 130125709:Brenner, Thorsten  |d 50000  |e 50000PB130125709  |k 0/50000/  |p 26 
999 |a KXP-PPN175353416X  |e 3904226835 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1038/s41467-021-21310-4"],"eki":["175353416X"]},"name":{"displayForm":["Alan Bénard, Anne Jacobsen, Maximilian Brunner, Christian Krautz, Bettina Klösch, Izabela Swierzy, Elisabeth Naschberger, Malgorzata J. Podolska, Dina Kouhestani, Paul David, Torsten Birkholz, Ixchel Castellanos, Denis Trufa, Horia Sirbu, Marcel Vetter, Andreas E. Kremer, Kai Hildner, Andreas Hecker, Fabian Edinger, Matthias Tenbusch, Petra Mühl-Zürbes, Alexander Steinkasserer, Enrico Richter, Hendrik Streeck, Marc M. Berger, Thorsten Brenner, Markus A. Weigand, Filip K. Swirski, Georg Schett, Robert Grützmann & Georg F. Weber"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"175353416X","physDesc":[{"extent":"8 S."}],"title":[{"title":"Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections","title_sort":"Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections"}],"person":[{"role":"aut","display":"Bénard, Alan","family":"Bénard","given":"Alan"},{"family":"Jacobsen","given":"Anne","display":"Jacobsen, Anne","role":"aut"},{"display":"Brunner, Maximilian","role":"aut","given":"Maximilian","family":"Brunner"},{"family":"Krautz","given":"Christian","display":"Krautz, Christian","role":"aut"},{"role":"aut","display":"Klösch, Bettina","family":"Klösch","given":"Bettina"},{"role":"aut","display":"Swierzy, Izabela","family":"Swierzy","given":"Izabela"},{"given":"Elisabeth","family":"Naschberger","display":"Naschberger, Elisabeth","role":"aut"},{"display":"Podolska, Malgorzata J.","role":"aut","given":"Malgorzata J.","family":"Podolska"},{"role":"aut","display":"Kouhestani, Dina","given":"Dina","family":"Kouhestani"},{"display":"David, Paul","role":"aut","given":"Paul","family":"David"},{"display":"Birkholz, Torsten","role":"aut","given":"Torsten","family":"Birkholz"},{"family":"Castellanos","given":"Ixchel","role":"aut","display":"Castellanos, Ixchel"},{"display":"Trufa, Denis","role":"aut","given":"Denis","family":"Trufa"},{"display":"Sirbu, Horia","role":"aut","given":"Horia","family":"Sirbu"},{"given":"Marcel","family":"Vetter","display":"Vetter, Marcel","role":"aut"},{"given":"Andreas E.","family":"Kremer","role":"aut","display":"Kremer, Andreas E."},{"display":"Hildner, Kai","role":"aut","given":"Kai","family":"Hildner"},{"family":"Hecker","given":"Andreas","display":"Hecker, Andreas","role":"aut"},{"display":"Edinger, Fabian","role":"aut","given":"Fabian","family":"Edinger"},{"family":"Tenbusch","given":"Matthias","role":"aut","display":"Tenbusch, Matthias"},{"role":"aut","display":"Mühl-Zürbes, Petra","family":"Mühl-Zürbes","given":"Petra"},{"display":"Steinkasserer, Alexander","role":"aut","given":"Alexander","family":"Steinkasserer"},{"display":"Richter, Enrico","role":"aut","given":"Enrico","family":"Richter"},{"given":"Hendrik","family":"Streeck","role":"aut","display":"Streeck, Hendrik"},{"display":"Berger, Marc Moritz","role":"aut","given":"Marc Moritz","family":"Berger"},{"role":"aut","display":"Brenner, Thorsten","given":"Thorsten","family":"Brenner"},{"family":"Weigand","given":"Markus A.","display":"Weigand, Markus A.","role":"aut"},{"display":"Swirski, Filip K.","role":"aut","given":"Filip K.","family":"Swirski"},{"role":"aut","display":"Schett, Georg","given":"Georg","family":"Schett"},{"display":"Grützmann, Robert","role":"aut","family":"Grützmann","given":"Robert"},{"display":"Weber, Georg Ferdinand","role":"aut","family":"Weber","given":"Georg Ferdinand"}],"relHost":[{"origin":[{"dateIssuedDisp":"[2010]-","publisher":"Springer Nature ; Nature Publishing Group UK","publisherPlace":"[London] ; [London]"}],"note":["Gesehen am 13.06.24"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"626457688","id":{"issn":["2041-1723"],"eki":["626457688"],"zdb":["2553671-0"]},"pubHistory":["2010-"],"part":{"volume":"12","year":"2021","extent":"8","pages":"1-8","text":"12(2021), Artikel-ID 1112, Seite 1-8"},"title":[{"title_sort":"Nature Communications","title":"Nature Communications"}],"disp":"Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infectionsNature Communications","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"]}],"origin":[{"dateIssuedDisp":"18 February 2021","dateIssuedKey":"2021"}],"note":["Gesehen am 02.09.2021"]} 
SRT |a BENARDALANINTERLEUKI1820 

Similar Items